- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03569189
Impact of a High Saturated Fat Diet on Fasted Systemic and White Adipose Tissue Inflammatory Responses
Impact of Short-term Overfeeding With a Saturated Fat-rich Diet on Fasted Systemic and White Adipose Tissue Inflammatory Responses
This study will investigate the effect of a 7-day westernised high-fat (65% of kilocalories), high-calorie (150% of requirements) diet on markers of inflammation in the blood and white adipose tissue. Participants will firstly complete a 3-day weight maintenance phase (Days 1-3) before completing a 7-day high fat diet intervention (Days 4-10). On days 4 and 11 participants will complete a laboratory visit where anthropometric measurements, blood and adipose samples will be collected.
The investigators hypothesise that consuming a high-fat, high-calorie diet for 7 days will alter the inflammatory responses in white adipose tissue and will induce metabolic endotoxaemia / systemic inflammation.
Study Overview
Status
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Leicestershire
-
Loughborough, Leicestershire, United Kingdom, LE11 3TU
- Loughborough University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion criteria:
- 18-40 years
- BMI = 21.0-29.9 kg/m2
- Male or female
- Physically active (> 3 x 30 min moderate exercise per week)
- Healthy
- No cardiometabolic (e.g. heart disease, high blood pressure, type 2 diabetes) or inflammatory illness
Exclusion criteria:
- Inactive (< 3 x 30 min moderate exercise per week)
- Smoker
- Women who are pregnant or lactating
- Medication/supplements known to interfere with study outcomes or prescribed antibiotics within the last 3 months
- Unstable weight history (≥3kg loss or gain in the previous 3 months)
- An allergy to lidocaine
- Food allergies (e.g. gluten, dairy) and intolerances (e.g. lactose) which could impede compliance to the diet
- Vegetarian/ vegan (as the high-fat diet is based on animal fats)
- Consumption of probiotics yogurts during or within the four weeks prior to the start of the study (e.g. Actimel, Activia, Yakult, Yeo Valley)
- Alcohol consumption >28 units per week for a man (i.e. not more than 14 pints of beer or 28 small glasses of wine) or >21 units per week for a woman (i.e. more than 10 and a half pints of beer or 21 small glasses of wine)
- Any other unusual medical history or diet and lifestyle habits or practices that would preclude volunteers from participating in a dietary intervention or metabolic study
- Restrained eaters (determined by Three Factor Eating Questionnaire)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: BASIC_SCIENCE
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: High Fat Diet
Participants will consume a high-fat, high-calorie diet for 7 days (i.e.
westernised diet) following a 3-day weight maintenance diet.
Measurements will be made pre- and post-high fat diet intervention.
|
Participants will consume a high fat diet for 7 days with 65% of energy from fat. The diet will also provide an energy excess at 150% of energy requirements. Participants will be provided with all of their meals and snacks throughout the study. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Protein expression (content and phosphorylation) of key markers of metabolic inflammation in white adipose tissue (for example assessment of NFKB/IKBa total protein and phosphorylation by western blot analysis)
Time Frame: Change between pre- and post-high fat diet (assessed on days 4 and 11)
|
This will be assessed following the collection of fasted white adipose tissue samples
|
Change between pre- and post-high fat diet (assessed on days 4 and 11)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Systemic Markers of Inflammation (for example CRP, TNFa and IL-6 concentrations, determined by spectrophotometric assay/ ELISA)
Time Frame: Change between pre- and post-high fat diet (assessed on days 4 and 11)
|
Assessed following the collection of fasted blood samples
|
Change between pre- and post-high fat diet (assessed on days 4 and 11)
|
Gene expression of key markers of metabolic inflammation in white adipose tissue
Time Frame: Change between pre- and post-high fat diet (assessed on days 4 and 11)
|
This will be assessed following the collection of fasted white adipose tissue samples
|
Change between pre- and post-high fat diet (assessed on days 4 and 11)
|
Fasting Serum Markers of Insulin Resistance (for example insulin and glucose concentrations, determined using an ELISA/ spectrophotometric assay)
Time Frame: Change between pre- and post-high fat diet (assessed on days 4 and 11)
|
Assessed following the collection of fasted blood samples
|
Change between pre- and post-high fat diet (assessed on days 4 and 11)
|
Fasting Serum Lipid Profile (for example total, HDL and LDL cholesterol, TAG and NEFA concentrations, measured using a spectrophotometric assay)
Time Frame: Change between pre- and post-high fat diet (assessed on days 4 and 11)
|
Assessed following the collection of fasted blood samples
|
Change between pre- and post-high fat diet (assessed on days 4 and 11)
|
Systemic Markers of Metabolic Endotoxemia (for example LBP and sCD14 concentrations, determined using an ELISA)
Time Frame: Change between pre- and post-high fat diet (assessed on days 4 and 11)
|
Assessed following the collection of fasted blood samples
|
Change between pre- and post-high fat diet (assessed on days 4 and 11)
|
Immune Cell Populations in the Blood
Time Frame: Change between pre- and post-high fat diet (assessed on days 4 and 11)
|
Assessed following the collection of fasted blood samples
|
Change between pre- and post-high fat diet (assessed on days 4 and 11)
|
Anthropometric Measurements (for example height and weight that will be aggregated to report BMI in kg/m^2)
Time Frame: Change between pre- and post-high fat diet (assessed on days 4 and 11)
|
Measured using standard equipment
|
Change between pre- and post-high fat diet (assessed on days 4 and 11)
|
Physical Activity
Time Frame: Habitual physical activity will be assessed for 3 days prior to commencing the high-fat diet intervention (days 1-3) and during the final 3 days of the intervention (days 8-10)
|
Assessed using Actigraph accelerometers
|
Habitual physical activity will be assessed for 3 days prior to commencing the high-fat diet intervention (days 1-3) and during the final 3 days of the intervention (days 8-10)
|
Collaborators and Investigators
Sponsor
Publications and helpful links
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- R18-P040
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cardiovascular Diseases
-
Medical College of WisconsinRecruitingCardiovascular Diseases | Cardiovascular Risk Factor | Cardiovascular HealthUnited States
-
Hospital Mutua de TerrassaCompleted
-
Oregon Health and Science UniversityCompletedCardiovascular Disease | Cardiovascular Risk FactorsUnited States
-
Women's College HospitalUniversity Health Network, Toronto; Sunnybrook Health Sciences Centre; Brigham... and other collaboratorsUnknownCARDIOVASCULAR DISEASESCanada, United States
-
Groupe Hospitalier Paris Saint JosephTerminatedCARDIOVASCULAR DISEASESFrance
-
University of FloridaUniversity of Alabama at Birmingham; Brown UniversityCompletedCardiovascular Disease | Psychosocial Influence on Cardiovascular DiseaseUnited States
-
VA Office of Research and DevelopmentNot yet recruitingCardiovascular DiseaseUnited States
-
Baptist Health South FloridaUniversity of California, Los Angeles; Quest Diagnostics-Nichols InsituteActive, not recruitingCardiovascular DiseaseUnited States
-
Laval UniversityActive, not recruitingCardiovascular DiseaseCanada
-
Penn State UniversityCalifornia Healthcare InstituteCompleted
Clinical Trials on High Fat Diet
-
Rutgers, The State University of New JerseyCompleted
-
Maastricht University Medical CenterCompleted
-
Zhejiang UniversityNational Natural Science Foundation of China; Chinese PLA General Hospital; National...Completed
-
University of Alabama at BirminghamSmartFoods, Inc.Completed
-
Laval UniversityRecruiting
-
Tufts UniversityCompletedDyslipidemia | Impaired Glucose Tolerance
-
University Hospital, LilleMinistry of Health, FranceCompletedMitochondrial Cytopathies DisordersFrance
-
Oregon Health and Science UniversityNational Institutes of Health (NIH)Recruiting
-
UCSF Benioff Children's Hospital OaklandNational Cattlemen's Beef AssociationCompletedHealthy | Cardiovascular Disease | Atherogenic DyslipidemiaUnited States
-
Hvidovre University HospitalUniversity of Copenhagen; Danish Research Centre for Magnetic ResonanceCompletedDiabetes | Metabolic Syndrome | NAFLD | Overweight and ObesityDenmark